Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CYBN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q2.23
N/A
-1.90
vs -2.28
Q3.23
N/A
-1.52
vs -1.90
Q4.23
N/A
-2.66
vs -1.52
Q1.24
N/A
-1.52
vs -1.90
Q2.24
N/A
-0.38
vs -1.90
Q3.24
N/A
-2.10
vs -1.52
Q4.24
N/A
-0.38
vs -2.66
Q1.25
N/A
-1.02
vs -1.52
Q2.25
N/A
-1.17
vs -0.38
Q3.25
N/A
-1.25
vs -2.10
Sales Growth
YoY
Current
Estimates
Q4.22
NA
NA vs NA
Q1.23
NA
NA vs NA
Q2.23
NA
NA vs NA
Q3.23
NA
NA vs NA
Q4.23
NA
NA vs NA
Q1.24
NA
NA vs NA
Q2.24
NA
NA vs NA
Q3.24
NA
NA vs NA
Q4.24
NA
NA vs NA
Q1.25
NA
NA vs NA
Return on Equity
QoQ
Q3.22
-16%
-0.16
vs -0.19
Q4.22
-19%
-0.19
vs -0.16
Q1.23
-28%
-0.28
vs -0.19
Q2.23
-33%
-0.33
vs -0.28
Q3.23
-16%
-0.16
vs -0.33
Q4.23
-25%
-0.25
vs -0.16
Q1.24
-7%
-0.07
vs -0.25
Q2.24
-5%
-0.05
vs -0.07
Q3.24
-22%
-0.22
vs -0.05
Q4.24
-4%
-0.04
vs -0.22
Institutionnal Ownership
QoQ
Q4.22
64
64
vs 50
28%
Q1.23
62
62
vs 64
-3%
Q2.23
56
56
vs 62
-10%
Q3.23
67
67
vs 56
20%
Q4.23
81
81
vs 67
21%
Q1.24
104
104
vs 81
28%
Q2.24
95
95
vs 104
-9%
Q3.24
42
42
vs 95
-56%
Q4.24
58
58
vs 42
38%
Q1.25
59
59
vs 58
2%
businesswire.com
7 hours ago
businesswire.com
17 hours ago
businesswire.com
17 hours ago
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Buy
Price Target
N/A(N/A)
Number of analyst
N/A
Last analyst upgrade/downgrade
No Data Available
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
AMEX
Unprofitable
Unprofitable
-0.14 ( -1.98%)
After-hours 6.97$
0.05 (0.72%)
Relative Strenght
8
Volume Buzz
8%
Earning Acce
Yes
Dist 52w H.
50%Relative Strength
CYBN
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|